Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $21,205 | 6 | 92.8% |
| Food and Beverage | $981.68 | 16 | 4.3% |
| Travel and Lodging | $664.48 | 2 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EMD Serono, Inc. | $11,755 | 6 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $3,604 | 6 | $0 (2017) |
| Genentech, Inc. | $2,970 | 1 | $0 (2021) |
| AbbVie, Inc. | $2,058 | 3 | $0 (2018) |
| Eisai Inc. | $1,700 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $339.00 | 1 | $0 (2019) |
| Ethicon Inc. | $253.70 | 5 | $0 (2023) |
| Varian Medical Systems, Inc. | $171.82 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $253.70 | 5 | Ethicon Inc. ($253.70) |
| 2021 | $2,970 | 1 | Genentech, Inc. ($2,970) |
| 2019 | $5,059 | 5 | EMD Serono, Inc. ($4,720) |
| 2018 | $9,132 | 4 | EMD Serono, Inc. ($7,035) |
| 2017 | $5,437 | 9 | AstraZeneca Pharmaceuticals LP ($3,604) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/28/2023 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $71.68 | General |
| Category: Endo-Mechanical | ||||||
| 02/28/2023 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Endo-Mechanical | ||||||
| 02/28/2023 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Endo-Mechanical | ||||||
| 02/28/2023 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Endo-Mechanical | ||||||
| 02/14/2023 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $62.02 | General |
| Category: Endo-Mechanical | ||||||
| 05/05/2021 | Genentech, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,970.00 | General |
| 10/28/2019 | EMD Serono, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,550.00 | General |
| 09/13/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $339.00 | General |
| 09/11/2019 | EMD Serono, Inc. | — | Food and Beverage | In-kind items and services | $75.81 | General |
| 09/11/2019 | EMD Serono, Inc. | — | Food and Beverage | In-kind items and services | $46.96 | General |
| 09/11/2019 | EMD Serono, Inc. | — | Food and Beverage | In-kind items and services | $46.81 | General |
| 10/23/2018 | EMD Serono, Inc. | — | Consulting Fee | Cash or cash equivalent | $6,710.00 | General |
| 09/28/2018 | EMD Serono, Inc. | — | Travel and Lodging | In-kind items and services | $325.48 | General |
| 08/30/2018 | Varian Medical Systems, Inc. | Radiation Oncology (Device) | Food and Beverage | In-kind items and services | $171.82 | General |
| Category: Devices | ||||||
| 01/12/2018 | AbbVie, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,925.00 | General |
| 11/09/2017 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $19.27 | General |
| 11/08/2017 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $113.23 | General |
| 08/08/2017 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Consulting Fee | Cash or cash equivalent | $3,350.00 | General |
| Category: Oncology | ||||||
| 06/15/2017 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $46.94 | General |
| Category: Oncology | ||||||
| 06/14/2017 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $110.91 | General |
| Category: Oncology | ||||||
| 06/14/2017 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $53.98 | General |
| Category: Oncology | ||||||
| 06/14/2017 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Oncology | ||||||
| 06/14/2017 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Oncology | ||||||
| 02/10/2017 | Eisai Inc. | — | Consulting Fee | Cash or cash equivalent | $1,700.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 218 | 534 | $247,602 | $22,304 |
| 2022 | 2 | 24 | 89 | $66,813 | $5,671 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 33 | 151 | $131,068 | $10,673 | 8.1% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 45 | 160 | $60,896 | $5,674 | 9.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 65 | 116 | $34,660 | $3,591 | 10.4% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 32 | 57 | $17,728 | $1,690 | 9.5% |
| 76098 | X-ray of surgical specimen | Facility | 2023 | 43 | 50 | $3,250 | $674.54 | 20.8% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 12 | 76 | $65,968 | $5,490 | 8.3% |
| 76098 | X-ray of surgical specimen | Facility | 2022 | 12 | 13 | $845.00 | $180.70 | 21.4% |
About Dr. Sandra Demaria, M.D
Dr. Sandra Demaria, M.D is a Anatomic Pathology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1942293675.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sandra Demaria, M.D has received a total of $22,851 in payments from pharmaceutical and medical device companies, with $253.70 received in 2023. These payments were reported across 24 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($21,205).
As a Medicare-enrolled provider, Demaria has provided services to 242 Medicare beneficiaries, totaling 623 services with total Medicare billing of $27,974. Data is available for 2 years (2022–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology
- Location New York, NY
- Active Since 08/29/2005
- Last Updated 08/30/2023
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1942293675
Products in Payments
- IMFINZI (Drug) $3,604
- Monarch Platform (Device) $253.70
- Radiation Oncology (Device) $171.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology Doctors in New York
Dr. Richard Axel, M.d, M.D
Anatomic Pathology — Payments: $96,602
Dr. Jeremy Segal, M.d., Ph.d, M.D., PH.D
Anatomic Pathology — Payments: $92,539
Marc Ladanyi, Md, MD
Anatomic Pathology — Payments: $74,599
Dr. Maureen Zakowski, Md, MD
Anatomic Pathology — Payments: $45,149
Victor Reuter, Md, MD
Anatomic Pathology — Payments: $44,326
Dr. Alexandros Polydorides, M.d., Ph.d, M.D., PH.D
Anatomic Pathology — Payments: $34,029